Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

{ "Comparing Internet-Based vs. Parent-Coached Therapy for Anxiety and OCD", "This study is comparing two types of therapy for children and teenagers aged 7 to 17 with anxiety and/or Obsessive Compulsive Disorder (OCD). One therapy is called Parent Coached Exposure Therapy, where parents learn from a therapist how to help their child. The other is Family Based, Internet-Based Cognitive Behavioral Therapy, which uses online lessons and videos for families. The goal is to see which approach is more effective at reducing anxiety symptoms, measured by a clinician-rated scale. We are looking for 174 participants who have significant anxiety or OCD symptoms. The study's current status is unclear.", "design": "This interventional study plans to enroll 174 participants to compare two different behavioral therapies.", "commitments": "You would have your child's anxiety severity measured at the start of the study, after 14 weeks of treatment, and again 1 month later (at week 18).", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for 1 month after treatment, with a final assessment at week 18.", }

Study design: Not specified.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Active, Not Recruiting

NAAges 7–17InterventionalTreatment

Baylor College of Medicine

~174 participants

Updated 2026-07-30 on ClinicalTrials.gov

What's tested:Parent Coached Exposure TherapyFamily Based, Internet-Based Cognitive Behavioral Therapy

At a glance

Recruiting sites

0 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Change in clinician-rated child anxiety severity (PARS) throughout the past week.

Measured over baseline (before treatment or week 1), post-treatment (week 14), 1 month follow up (Week 18)

Conditions

Obsessive Compulsive Disorder (OCD)

Anxiety Disorder of Childhood or Adolescence

Social Anxiety Disorder of Childhood

Generalized Anxiety Disorder (GAD)

Separation Anxiety Disorder

Panic Disorder

Panic Attacks

Panic Disorder (With or Without Agoraphobia)

Phobia, Specific

Where it's being run

1 sites across 1 states

Texas1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

The child is between the ages of 7 to 17 years inclusive at enrollment.

The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS).

The child is appropriate for anxiety-focused treatment (e.g., anxiety or OCD is the primary or co-primary problem as diagnosed using the DIAMOND-KID).

One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration).

The participating parent/guardian lives with their child at least 50% of the time per self-report.

Both parent and child can read and understand English.

The participant has an IQ above 69, based on the KBIT-2, another valid test or clinician judgement (e.g., a previous assessment conducted, and report shared with study team).

Participants must be in the state of Texas for treatment sessions/assessments.

Exclusion

The child has a diagnosis of a lifetime psychotic disorder and/or conduct disorder.

The child has significant, current and active suicidality/homicidality and/or self-injury requiring medical intervention.

The child has limited verbal communication abilities (e.g., no independent verbal communication).

The child is receiving concurrent psychotherapy with anxiety and/or OCD as the primary focus. They can pause ongoing therapy to enroll.

The child has initiated new antidepressant medication within 12-weeks of assessment (4-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.

The child has changed psychotropic medication dosage within 4-weeks of assessment (2-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.

The child requires a higher level of care than can be provided through the study (e.g., significant, current suicidal ideation).

What this trial measures

Change in clinician-rated child anxiety severity (PARS) throughout the past week.baseline (before treatment or week 1), post-treatment (week 14), 1 month follow up (Week 18)
Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 30.

Trialytics